Why the study?
Little attention had been given to the association between triglyceride glucose-body mass index (TyG-BMI) and cardiovascular disease mortality in patients undergoing peritoneal dialysis.
Does a higher baseline triglyceride glucose-body mass index (TyG-BMI) increase the risk of cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis?
Population
2,335 incident peritoneal dialysis patients in southern China
Comparison
TyG-BMI levels
Design
Single-center retrospective cohort study
Follow-up
Median 46.6 months
Authors
Loading...
TyG-BMI may aid risk stratification in peritoneal dialysis; leaves open its added value beyond standard predictors.
Does a higher baseline triglyceride glucose-body mass index (TyG-BMI) increase the risk of cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis?
Higher baseline TyG-BMI is independently associated with an increased risk of cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis, suggesting its utility as a prognostic cardiometabolic marker.
Zhan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: